Page 7 - PRESENTATION
P. 7
Risk Adapted Treatment of NMIBC
Transurethral resection of bladder tumor (TURBT) + Single dose chemo
Stratification into risk group
Low risk Intermediate risk High risk Consider early
treatment + cytology 1yr maintenance BCG for 3yr T1HG, or T1 with
1L Monitoring via cystoscopy BCG or chemo. induction + Repeat TURBT cystectomy if:
T1HG + CIS,
multiple/large
variant histology
treatment Switch to BCG or chemo GEM/DOC Radical RC for HG T1
Consider
2L depending on 1L treatment BCG/IFN, etc Cystectomy eligible
recurrence if
treatment BCG/IFN, etc Cystectomy eligible
Consider
RC for all
3L Alternative chemotherapy GEM/DOC Radical patients if
